FDA: Orientation for Early Stage Startups
Y Combinator
MARCH 2, 2021
Historically, most companies developing “digital health” products took great pains to steer clear of product functionality that necessitated FDA oversight. In recent years, however, some new classes of products have been a priori FDA regulated, such as digital therapeutics (e.g. Conclusion.
Let's personalize your content